Digitoxin - Class II - ANVISA Registration 80146502381
Access comprehensive regulatory information for Digitoxin - Class II in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80146502381 and manufactured by BIOKIT SA. The registration is held by ABBOTT LABORATORIOS DO BRASIL LTDA with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
80146502381
25351212405202334
56998701000116
Company Information
Dates and Status
May 15, 2023
VIGENTE
09/18/2025 19:00:01
DIGOXIN - CLASS II
Família Atellica CH Digoxina (Dgn)
SIEMENS HEALTHCARE DIAGNOSTICS INC.
10345162194
Feb 05, 2018
DIGOXIN
Família MAGLUMI Digoxina (CLIA)
Not specified
80102513357
Jan 20, 2025
DIGOXIN
Família MAGLUMI Digoxina (CLIA)
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
80102513357
Jan 20, 2025
MYOGLOBIN - CLASS II
Família Alinity c Myoglobin
BIOKIT, S.A.
80146502299
Sep 24, 2020
MYOGLOBIN - CLASS II
Família Alinity i STAT Myoglobin
ABBOTT IRELAND DIAGNOSTICS DIVISION
80146502317
Dec 10, 2020